ArticleInternational journal of retina and vitreous2025
Early versus late silicone oil tamponade removal after rhegmatogenous retinal detachment: a retrospective real world comparative study.
Article in International journal of retina and vitreous, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Silicone oil-associated visual loss in macula-on rhegmatogenous retinal detachment - does the tamponade duration affect the outcome?BMC ophthalmology · 2026Article
- Effect of silicone oil removal timing on functional and structural outcomes in primary rhegmatogenous retinal detachment.International journal of retina and vitreous · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTo evaluate postoperative outcomes, including redetachment rates, in eyes with rhegmatogenous retinal detachment (RRD) following early or late removal of silicone oil (ROSO).
methodsThis retrospective single-center study included 58 pseudophakic eyes that underwent 23-gauge pars plana vitrectomy (PPV) with silicone oil endotamponade (SOE). Patients were divided into two groups: Group I (ROSO ≤ 12 weeks) and Group II (ROSO > 12 weeks) with SOE duration of 2.3 +/- 0.7 months and 5.2 +/- 1.9 months, respectively. Clinical outcomes, including redetachment rates, best corrected visual acuity (BCVA), cystoid macular edema (CME), epiretinal membrane (ERM) formation, and intraocular pressure (IOP) changes, were analyzed. Kaplan-Meier estimation and Log-Rank tests were used to assess redetachment.
resultsRedetachment occurred in a total of 13 eyes (22% of patients) (Group I: 7 (21%), Group II: 6 (23%); p = 1.00). The cumulative incidence of redetachment was comparable between groups (Log-Rank test: p = 0.88). Final BCVA at the last follow-up showed no significant difference between Group I (0.8 ± 0.5 logMAR) and Group II (0.8 ± 0.7 logMAR; p = 0.36). Postoperative incidences of CME (Group I: 13 (41%), Group II: 9 (35%) p = 0.78), ERM (Group I: 13 (41%), Group II: 7 (27%) p = 0.40), and elevated IOP (Group I: 7 (22%), Group II: 7 (27%) p = 0.76) were also comparable between groups.
conclusionsEarly ROSO (≤ 3 months) does not appear to increase the risk of retinal redetachment or adversely affect visual and anatomical outcomes. These findings support the feasibility of earlier ROSO in selected cases, potentially reducing the risk of silicone oil-related complications.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.